You searched for Parkinson's - Page 6 of 20

Best in Biotech 11 Jun 2024

Finland: Pushing biotech forward in the land of a thousand lakes

…of CDNF. HER-096 targets the unfolded protein response and brain inflammation triggered by alpha-synuclein aggregation, key factors in the progression of Parkinson’s disease. The drug’s ability to cross the blood-brain…

June 11, 2024 - 7 minutesmins - By Jules Adam

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis…

October 13, 2017 - 2 minutesmins - By Alex Dale

News and Trends 11 Oct 2016

World Mental Health Day: How is Biotech Helping the Cause?

…Alzheimer’s, while Parkinson’s affects 6.3 million people. Current treatments deal with symptoms but cannot stop the progression of the disease. We interviewed the CSO of the Dementia Discovery Fund earlier…

October 11, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

BenevolentAI Artificial Intelligence Fundraising

News and Trends 19 Apr 2018

Major $115M Fundraising Fuels AI Drug Development

…diseases such as motor neuron disease and Parkinson’s that have been difficult to understand and treat up until now. Specifically, the technology can identify the molecular signs of a disease…

April 19, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 20 Dec 2022

Watch: IRLAB CEO Richard Godfrey

IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company’s most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in phase IIb and are…

December 20, 2022 - 1 minutemin - By Jim Cornall

News and Trends 11 Jul 2023

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

…NodThera, said: “Taken together, these initial findings represent the first unambiguous demonstration of modulation of neuroinflammation in a human population with an NLRP3 inflammasome inhibitor. In designing our Parkinson’s disease…

July 11, 2023 - 3 minutesmins - By Jim Cornall

20S proteasome activation: Berlin biotech Booster Therapeutics secures $15 million for innovative therapies to tackle neurodegenerative diseases

News and Trends 15 Oct 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

…like Parkinson’s and Alzheimer’s. “We’re starting in neurodegenerative diseases, such as Parkinson’s and Alzheimer’s. We know that proteasome dysfunction is present in these diseases, and multiple pathways are going wrong,…

October 15, 2024 - 6 minutesmins - By Jules Adam

Best in Biotech 25 Jun 2024

Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024

…Parkinson’s disease and other neurodegenerative disorders. Inhibikase’s work is based on targeting Abelson tyrosine kinases (c-Abl), which play an important role in neurodegeneration. Inhibikase employs its proprietary RAMP (Re-engineering Approach…

June 25, 2024 - 7 minutesmins - By Jules Adam

Best in Biotech 13 Feb 2025

Seven companies using metabolomics to decode biology

…its lead program. Sinopia Biosciences Disease area: Parkinson’s disease Candidate: SB-0110 Recent news: Received 2 SBIR grants in 2024 Sinopia Biosciences leverages its proprietary artificial intelligence and machine learning (AI/ML)…

February 13, 2025 - 9 minutesmins - By Jules Adam

News and Trends 15 Jan 2018

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

…blood-brain barrier. Neurodegenerative diseases are a hot topic, with age-related diseases like Alzheimer’s and Parkinson’s rising in prevalence. In the US alone, 5 million people suffer from Alzheimer’s disease, 1…

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 12 Dec 2024

Top biotech deals of November 2024

…roll Partnerships focused on small molecules continue to be forged this month. U.S.-based Vesalius has partnered with GSK to develop small molecule inhibitor drugs for Parkinson’s disease. Vesalius will leverage…

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

Podcast 12 Jan 2024

Could natural killer cells transform Alzheimer’s treatment?

…a few years ago, I think that will still be pretty dramatic.” Song said there are no side effects with the process. Future plans: NK cells for Parkinson’s disease and…

January 12, 2024 - 6 minutesmins - By Jim Cornall

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Finland: Pushing biotech forward in the land of a thousand lakes

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

World Mental Health Day: How is Biotech Helping the Cause?

Major $115M Fundraising Fuels AI Drug Development

Watch: IRLAB CEO Richard Godfrey

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

Booster launches to treat neurodegenerative diseases with proteasome activation

Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024

Seven companies using metabolomics to decode biology

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

Top biotech deals of November 2024

Could natural killer cells transform Alzheimer’s treatment?

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!